PNS|Hyderabad
Industries Minister KT Rama Rao announced on Saturday that ‘BioAsia 2024’ will be held from February 26 to 28, 2024. The 21st edition of BioAsia promises to be an extraordinary platform where Data and AI will converge to redefine possibilities across the life sciences and healthcare sectors.
Themed ‘Data and AI: Redefining Possibilities,’ BioAsia 2024 will explore the pivotal role of data-driven technologies and artificial intelligence in shaping the future of healthcare, pharmaceuticals and biotechnology.
As the world increasingly harnesses the power of digital innovation, the theme aptly underscores the immense potential that lies in the intersection of technology and life sciences.
KTR’s statement, ‘Hyderabad is the place where Technology meets Biology and Data Sciences meets Life Sciences,” captures the essence of the city’s prowess in combining technology with life sciences.BioAsia 2024, which is being organised in partnership with EY, will delve deep into how the fusion of data sciences and life sciences can usher in transformative breakthroughs, paving the way for a healthier and more sustainable future.
BioAsia has consistently risen as a global platform that fosters meaningful dialogues among industry leaders, policymakers, researchers and innovators. BioAsia 2024 is set to elevate this legacy by assembling global leaders and participants from around 50 countries, fostering collaborations and partnerships that transcend geographical boundaries.
Speaking about BioAsia 2024, KTR said, “BioAsia has always been a catalyst for transformative ideas and partnerships. The theme of Data and AI speaks of Hyderabad’s unique convergence of technology and life sciences, shaping a new era of healthcare. This flagship event is a testament to our commitment to fostering collaborations that drive progress. With the world’s leading minds converging in Hyderabad, we will explore the uncharted frontiers of this transformative era.”
“In an era marked by breakthroughs in genomics, precision medicine and digital health, the convergence of data and AI promises to reshape research, diagnostics, treatment and patient care. This year’s theme encapsulates the profound impact of data-driven technologies and artificial intelligence on healthcare, biotechnology, pharmaceuticals and medical devices. BioAsia 2024 will unlock new dimensions in the world of life sciences and healthcare through the lens of Data and AI. It’s an event not to be missed,” said Shakthi M. Nagappan, the CEO of Telangana Life Sciences and BioAsia of the TS Government.
Data and AI are the driving forces behind cutting-edge advancements that have the potential to redefine healthcare globally. BioAsia 2024 promises to be a landmark event that will set the stage for meaningful conversations, innovations and collaborations, driving the life sciences and healthcare sectors to new horizons. It is an event that encapsulates the spirit of innovation and convergence that Hyderabad embodies.
“BioAsia 2024 is the embodiment of our vision to harness the potential of Data and AI to redefine healthcare globally. BioAsia is the perfect platform to explore the synergy between Data, AI and Life Sciences, propelling us into a future of transformative healthcare,” said Jayesh Ranjan, IAS, the Principal Secretary (I&C).
With Hyderabad as backdrop, BioAsia 2024 promises to be an epicentre of forward-thinking ideas, groundbreaking innovations and influential partnerships that will shape the future of life sciences and healthcare on a global scale. In addition to global leaders from various sectors, the event will mark the presence of over 50 countries, fostering cross-border collaboration. The Minister also unveiled the website for the event www.bioasia.in/2024 containing info about the event.
“Artificial intelligence and machine learning are exerting a transformative effect on the life sciences industry. Gen AI, the recent buzzword is a new addition to the list of transformative forces. Although at an early stage of adoption, the life sciences industry is likely to find numerous future use of these transformative technologies which could be the realm of imagination today. BioAsia 2024’s theme ‘Data and Artificial Intelligence: redefining possibilities’ will unleash those exciting possibilities of technology in unlocking the power of data. BioAsia has truly been the landmark global life sciences event in bringing together life sciences and healthcare stakeholders across the globe to review opportunities for creating a successful life sciences economy. We at EY are delighted to be associated as the knowledge partner for the event and contribute to this journey,” said Suresh Subramanian, Partner and National Life Sciences Leader, at Ernst & Young LLP.
